Matsushita Electric Industrial Co., Ltd.

Matsushita Graphic Communication Systems, Inc.

Dr. Falk Pharma Gmbh

Matsushita Graphic Communication, Inc.

Morio Iwasaki

Hiroki Nishii

Katsumi Nagano

Masao Tamura

Toshiro Iizuka

Hiroyuki Mizokawa

Tomoo Hori

Toshiyuki Itabashi

Takashi Kuwabara

Susumu Ibaraki

Toshiaki Mori

Junichi Ogawa

Toshikazu Hattori

Toshihiro Kumano

Hiroyuki Nose

Hajime Takayama

Hiroshi Okano

Shoji Kondo

Mikiro Ichijima

Yoji Yamada

Satoru Kotani

Provided is an enema for rectal application containing budesonide as an active ingredient in order to treat an inflammatory bowel disease, or to prevent a relapse. The enema for rectal application contains budesonide as the active ingredient, in which 1.5 to 2.5 mg of budesonide per dose is administered twice a day for 12 weeks in order to treat an inflammatory bowel disease, or to prevent a relapse. The enema for rectal application comprises several doses whereby the most preferable dose of budesonide is 2.0 mg per dose. The enema for rectal application is taken in order to treat ulcerative colitis or Crohn's disease, or to prevent a relapse; has a foamy, more rigid to a more liquid, gel-like structure.

Enema for rectal application

In a display system, a projector is mounted inside a vehicle, and emits a light beam, which is generated based on an image signal, toward an opening formed at a portion near a rear end of the vehicle. An exterior screen is extendable toward the opening and is made of a material having low stiffness. While being extended toward the opening, the exterior screen displays an image by allowing the light beam emitted by the projector to pass therethrough. A screen housing unit is mounted on or near one of a rear hatch and a back door of the vehicle for accommodating the exterior screen.

Growing community of inventors

Tokyo, Japan

Morio Iwasaki